Revista de la Facultad de Medicina

Fibrodysplasia ossificans progressiva: Report of the first Guatemalan case

DOI: https://doi.org/10.37345/23045329.v1i34.92

Case reports | Publicado: 2023-07-28

Autores:

  • Marcela Elizabeth Orozco Orozco
    Hospital General San Juan de Dios
  • Anna Yurrita Pocasangre
    Hospital Roosevelt
  • María Antonieta Sandoval Vargas
    Hospital Roosevelt
  • Julio Rafael Cabrera Valverde
    Hospital Roosevelt

Fibrodysplasia Ossificans Progressiva (FOP) is a rare, complex, autosomal dominant inherited disease caused by a heterozygous mutation of the ACVR1 gene on chromosome 2q24 (OMIM 135100), with a prevalence of 1 in 2 million worldwide. It is characterized by progressive heterotopic ossifications involving skeletal muscle, fasciae, tendons and ligaments. Diagnosis is based on clinical history and soft tissue injuries, with imaging studies supporting the identification of such ossifications. It is confirmed by DNA analysis of the ACVR1 gene via sequencing. Currently there is no definitive and curative therapy. The aim of this article is to present a clinical case of a 3-year-old girl with the clinical and radiological diagnosis of FOP.

Akyuz, G., Gencer-Atalay, K., Ata, P. Fibrodysplasia ossificans progressiva. Current Opinion in Pediatrics, 2019, 31(6), 716–722. https://doi.org/10.1097/mop.0000000000000802

Akesson, L. S., & Savarirayan, R. Fibrodysplasia Ossificans Progressiva. Adam, M.P., Mirzaa, G.M., Pagon R.A., et al., GeneReviews®, University of Washington, Seattle. 2020. https://www.ncbi.nlm.nih.gov/books/NBK1116

Bauer, A. H., Bonham, J., Gutierrez, L., Hsiao, E. C., & Motamedi, D. Fibrodysplasia ossificans progressiva: a current review of imaging findings. Skeletal radiology, 2018, 47(8), 1043–1050. https://doi.org/10.1007/s00256-018-2889-5

Carvalho, D., Navarro, M., Martins, B., Coelho, K., Mello, W., Takata, R., & Speck-Martins, C. Mutational screening ofACVR1gene in Brazilian fibrodysplasia ossificans progressiva patients. Clinical Genetics, 2010, 77(2), 171–176. doi:10.1111/j.1399-0004.2009.01256.x

De Brasi, D., Orlando, F., Gaeta, V., De Liso, M., Acquaviva, F., Martemucci, L., Mastrominico, A., & Di Rocco, M. Fibrodysplasia Ossificans Progressiva: A Challenging Diagnosis. Genes, 2021, 12(8), 1187. https://doi.org/10.3390/genes12081187

Eekhoff, E. M. W., de Ruiter, R. D., Smilde, B. J., Schoenmaker, T., de Vries, T. J., Netelenbos, C., Hsiao, E. C., Scott, C., Haga, N., Grunwald, Z., De Cunto, C. L., di Rocco, M., Delai, P. L. R., Diecidue, R. J., Madhuri, V., Cho, T. J., Morhart, R., Friedman, C. S., Zasloff, M., Pals, G., Micha, D., et. al. Gene Therapy for Fibrodysplasia Ossificans Progressiva: Feasibility and Obstacles. Human gene therapy, 2022, 33(15-16), 782–788. https://doi.org/10.1089/hum.2022.023

Elamin, M., Almutasim Ibrahim, A., & Omer, A. Fibrodisplasia Osificante Progresiva: Reporte De Cuatro Casos. Cureus, 2022, 14 (3), e23392. https://doi.org/10.7759/cureus.23392

Kaplan, FS, Chakkalakal, SA & Shore, EM. Fibrodisplasia osificante progresiva: mecanismos y modelos de metamorfosis esquelética. Modelos y mecanismos de enfermedad, 2012, 5 (6), 756–762. https://doi.org/10.1242/dmm.010280

Kaplan, F. S., Al Mukaddam, M., & Pignolo, R. J. Longitudinal patient-reported mobility assessment in fibrodysplasia ossificans progressiva (FOP). Bone, 2018, 109, 158–161. https://doi.org/10.1016/j.bone.2017.06.005

Pignolo, R. J., Shore, E. M., & Kaplan, F. S. Fibrodysplasia ossificans progressiva: clinical and genetic aspects. Orphanet journal of rare diseases, 2011, 6, 80. https://doi.org/10.1186/1750-1172-6-80

Pignolo, R. J., Baujat, G., Brown, M. A., De Cunto, C., Di Rocco, M., Hsiao, E. C., Keen, R., Al Mukaddam, M., Sang, K. L. Q., Wilson, A., White, B., Grogan, D. R., & Kaplan, F. S. Natural history of fibrodysplasia ossificans progressiva: cross-sectional analysis of annotated baseline phenotypes. Orphanet journal of rare diseases, 2019, 14(1), 98. https://doi.org/10.1186/s13023-019-1068-7

Smilde, B. J., Botman, E., de Ruiter, R. D., Smit, J. M., Teunissen, B. P., Lubbers, W. D., Schwarte, L. A., Schober, P., & Eekhoff, E. M. W. Monitoring and Management of Fibrodysplasia Ossificans Progressiva: Current Perspectives. Orthopedic research and reviews, 2022, 14, 113–120. https://doi.org/10.2147/ORR.S337491

Towler, OW & Shore, EM Señalización de BMP y desarrollo esquelético en fibrodisplasia osificante progresiva (FOP). Dinámica del desarrollo: una publicación oficial de la Asociación Estadounidense de Anatomistas, 2022, 251 (1), 164–177. https://doi.org/10.1002/dvdy.387

Valer, Sánchez-de-Diego, Pimenta-Lopes, Rosa & Ventura. Función ACVR1 en Salud y Enfermedad. Cells, 2019, 8 (11), 1366. MDPI AG. http://dx.doi.org/10.3390/cells8111366

Yang, Y. S., Kim, J. M., Xie, J., Chaugule, S., Lin, C., Ma, H., Hsiao, E., Hong, J., Chun, H., Shore, E. M., Kaplan, F. S., Gao, G., & Shim, J. H. Suppression of heterotopic ossification in fibrodysplasia ossificans progressiva using AAV gene delivery. Nature communications, 2022, 13(1), 6175. https://doi.org/10.1038/s41467-022-33956-9

Meyers, C., Lisiecki, J., Miller, S., Levin, A., Fayad, L., Ding, C., Sono, T., McCarthy, E., Levi, B., & James, A. W. Heterotopic Ossification: A Comprehensive Review. JBMR plus, 2019, 3(4), e10172. https://doi.org/10.1002/jbm4.10172

https://revista-medicina.ufm.edu

Facultad de Medicina de la Universidad Francisco Marroquín

Email: revistamedicina@ufm.edu

ISSN online 2304-5353 / ISSN printed 2304-5329

 

Cómo citar

Fibrodysplasia ossificans progressiva: Report of the first Guatemalan case. (2023). Revista De La Facultad De Medicina, 1(34), 86-93. https://doi.org/10.37345/23045329.v1i34.92